As COVID-19 has had a profound impact on liver transplantation and patients with advanced chronic liver disease, AASLD and American Society of Transplantation (AST) have teamed up to provide an update on the management of COVID-19 in transplant candidates and recipients.
This webinar will:
* Discuss emerging data on treatment and clinical outcomes among patients with chronic liver disease and cirrhosis with COVID-19
* Describe current approaches to treatment and immunosuppression adjustment in liver transplant recipients with COVID-19
* Consider whether clinical outcomes among liver transplant recipients are different then non-transplant patients with COVID-19
* Discuss the complex management decisions that occur in the peri-transplant period for patients with COVID-19
